Skip to main content

A-S Medication Solutions Announces Strategic Transition

LIBERTYVILLE, Ill., July 01, 2024 (GLOBE NEWSWIRE) -- A-S Medication Solutions (ASM) today announced a strategic transition of its relationship with Triple Aim Consulting, LLC (“TAC”).

For a number of years, ASM has had a consulting agreement with TAC for TAC to assist ASM in managing client accounts. That consulting agreement ended on June 28, 2024.

“ASM is committed to increasing access to medications all across the United States,” said ASM CEO Matt Hoff.  “We are proud of our tireless dedication to serving patients in all 50 states.”

Matt Hoff 
Chief Executive Officer 
(678) 488-7524 

https://www.a-smeds.com/testimonials


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.72
-1.60 (-0.76%)
AAPL  274.62
-3.50 (-1.26%)
AMD  216.00
+7.56 (3.63%)
BAC  56.41
-0.12 (-0.21%)
GOOG  324.40
+1.30 (0.40%)
META  677.22
+15.76 (2.38%)
MSFT  413.60
+12.46 (3.11%)
NVDA  190.04
+4.63 (2.50%)
ORCL  156.59
+13.77 (9.64%)
TSLA  417.32
+6.21 (1.51%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.